Home > News > MDA Awards Largest Private Company Grant to Asklepios
July 22nd, 2004
MDA Awards Largest Private Company Grant to Asklepios
Abstract:
Asklepios, a startup biotechnology firm focused on delivery of gene therapies, has received a $1.6 million grant from the Muscular Dystrophy Association to pursue possible gene therapies to treat muscular dystrophy. Asklepios describes itself as a company focused on the disease therapies delivered to genes through the design of proprietary biological nano particles.
Source:
LocalTechWire.com
Bookmark:
| Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over 14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||